New Releases from NCBI BookshelfRuxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal).Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal).
Post Content
